vs
Mirion Technologies, Inc.（MIR）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Mirion Technologies, Inc.的季度营收约是REPLIGEN CORP的1.3倍（$257.6M vs $197.9M），Mirion Technologies, Inc.同比增速更快（27.5% vs 13.6%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 11.5%）
Mirion Technologies是全球领先的辐射检测、监测与安全解决方案提供商，核心产品涵盖个人剂量测量系统、辐射成像设备及辐射风险管理软件，服务核电、医疗、国防、工业等多个核心领域，客户遍布北美、欧洲及亚太地区。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
MIR vs RGEN — 直观对比
营收规模更大
MIR
是对方的1.3倍
$197.9M
营收增速更快
MIR
高出13.9%
13.6%
两年增速更快
RGEN
近两年复合增速
11.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $257.6M | $197.9M |
| 净利润 | — | $13.3M |
| 毛利率 | 46.2% | 52.5% |
| 营业利润率 | 1.4% | 9.0% |
| 净利率 | — | 6.7% |
| 营收同比 | 27.5% | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益（稀释后） | $-0.01 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MIRRGEN
| Q1 26 | $257.6M | — | ||
| Q4 25 | $277.4M | $197.9M | ||
| Q3 25 | $223.1M | $188.8M | ||
| Q2 25 | $222.9M | $182.4M | ||
| Q1 25 | $202.0M | $169.2M | ||
| Q4 24 | $254.3M | $174.1M | ||
| Q3 24 | $206.8M | $154.9M | ||
| Q2 24 | $207.1M | $154.1M |
净利润MIRRGEN
| Q1 26 | — | — | ||
| Q4 25 | $17.3M | $13.3M | ||
| Q3 25 | $2.9M | $14.9M | ||
| Q2 25 | $8.3M | $14.9M | ||
| Q1 25 | $300.0K | $5.8M | ||
| Q4 24 | $15.0M | $-30.3M | ||
| Q3 24 | $-13.6M | $-654.0K | ||
| Q2 24 | $-11.7M | $3.3M |
毛利率MIRRGEN
| Q1 26 | 46.2% | — | ||
| Q4 25 | 48.8% | 52.5% | ||
| Q3 25 | 46.8% | 53.2% | ||
| Q2 25 | 46.0% | 50.0% | ||
| Q1 25 | 47.6% | 53.6% | ||
| Q4 24 | 48.1% | 26.1% | ||
| Q3 24 | 44.9% | 50.0% | ||
| Q2 24 | 47.0% | 49.8% |
营业利润率MIRRGEN
| Q1 26 | 1.4% | — | ||
| Q4 25 | 9.2% | 9.0% | ||
| Q3 25 | 3.3% | 8.9% | ||
| Q2 25 | 4.4% | 7.6% | ||
| Q1 25 | 4.3% | 3.9% | ||
| Q4 24 | 11.4% | -17.7% | ||
| Q3 24 | -0.8% | -5.1% | ||
| Q2 24 | 1.1% | 1.0% |
净利率MIRRGEN
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | 6.7% | ||
| Q3 25 | 1.3% | 7.9% | ||
| Q2 25 | 3.7% | 8.2% | ||
| Q1 25 | 0.1% | 3.4% | ||
| Q4 24 | 5.9% | -17.4% | ||
| Q3 24 | -6.6% | -0.4% | ||
| Q2 24 | -5.6% | 2.2% |
每股收益（稀释后）MIRRGEN
| Q1 26 | $-0.01 | — | ||
| Q4 25 | $0.07 | $0.24 | ||
| Q3 25 | $0.01 | $0.26 | ||
| Q2 25 | $0.03 | $0.26 | ||
| Q1 25 | $0.00 | $0.10 | ||
| Q4 24 | $0.08 | $-0.55 | ||
| Q3 24 | $-0.07 | $-0.01 | ||
| Q2 24 | $-0.06 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $397.9M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $1.9B | $2.1B |
| 总资产 | $3.5B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资MIRRGEN
| Q1 26 | $397.9M | — | ||
| Q4 25 | $412.3M | $767.6M | ||
| Q3 25 | $933.2M | $748.7M | ||
| Q2 25 | $262.6M | $708.9M | ||
| Q1 25 | $185.8M | $697.2M | ||
| Q4 24 | $175.2M | $757.4M | ||
| Q3 24 | $133.3M | $784.0M | ||
| Q2 24 | $122.2M | $809.1M |
总债务MIRRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | $444.8M | $537.9M | ||
| Q2 25 | $444.9M | — | ||
| Q1 25 | $686.6M | — | ||
| Q4 24 | $686.4M | $525.6M | ||
| Q3 24 | $685.1M | — | ||
| Q2 24 | $684.1M | — |
股东权益MIRRGEN
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $1.8B | $2.1B | ||
| Q2 25 | $1.5B | $2.1B | ||
| Q1 25 | $1.5B | $2.0B | ||
| Q4 24 | $1.5B | $2.0B | ||
| Q3 24 | $1.5B | $2.0B | ||
| Q2 24 | $1.5B | $2.0B |
总资产MIRRGEN
| Q1 26 | $3.5B | — | ||
| Q4 25 | $3.6B | $2.9B | ||
| Q3 25 | $3.5B | $2.9B | ||
| Q2 25 | $2.7B | $2.9B | ||
| Q1 25 | $2.6B | $2.9B | ||
| Q4 24 | $2.6B | $2.8B | ||
| Q3 24 | $2.7B | $2.8B | ||
| Q2 24 | $2.6B | $2.9B |
负债/权益比MIRRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | 0.24× | 0.26× | ||
| Q2 25 | 0.30× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.46× | 0.27× | ||
| Q3 24 | 0.45× | — | ||
| Q2 24 | 0.45× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $18.9M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流MIRRGEN
| Q1 26 | $18.9M | — | ||
| Q4 25 | $73.0M | $25.7M | ||
| Q3 25 | $22.3M | $48.1M | ||
| Q2 25 | $12.4M | $28.6M | ||
| Q1 25 | $35.6M | $15.0M | ||
| Q4 24 | $60.8M | $39.2M | ||
| Q3 24 | $17.1M | $49.3M | ||
| Q2 24 | $15.2M | $42.2M |
自由现金流MIRRGEN
| Q1 26 | — | — | ||
| Q4 25 | $63.2M | $17.6M | ||
| Q3 25 | $13.0M | $43.4M | ||
| Q2 25 | $3.6M | $21.5M | ||
| Q1 25 | $27.1M | $11.4M | ||
| Q4 24 | $49.1M | $33.6M | ||
| Q3 24 | $3.9M | $42.3M | ||
| Q2 24 | $4.1M | $37.4M |
自由现金流率MIRRGEN
| Q1 26 | — | — | ||
| Q4 25 | 22.8% | 8.9% | ||
| Q3 25 | 5.8% | 23.0% | ||
| Q2 25 | 1.6% | 11.8% | ||
| Q1 25 | 13.4% | 6.8% | ||
| Q4 24 | 19.3% | 19.3% | ||
| Q3 24 | 1.9% | 27.3% | ||
| Q2 24 | 2.0% | 24.3% |
资本支出强度MIRRGEN
| Q1 26 | — | — | ||
| Q4 25 | 3.5% | 4.1% | ||
| Q3 25 | 4.2% | 2.5% | ||
| Q2 25 | 3.9% | 3.9% | ||
| Q1 25 | 4.2% | 2.1% | ||
| Q4 24 | 4.6% | 3.2% | ||
| Q3 24 | 6.4% | 4.5% | ||
| Q2 24 | 5.4% | 3.1% |
现金转化率MIRRGEN
| Q1 26 | — | — | ||
| Q4 25 | 4.22× | 1.93× | ||
| Q3 25 | 7.69× | 3.23× | ||
| Q2 25 | 1.49× | 1.92× | ||
| Q1 25 | 118.67× | 2.57× | ||
| Q4 24 | 4.05× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MIR
| Product | $197.0M | 76% |
| Service | $60.6M | 24% |
RGEN
暂无分部数据
